These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12583560)

  • 1. Nosocomial Stenotrophomonas maltophilia strain with a broad host range ability to transfer antibiotic resistance.
    Babálová M; Blahová J; Králiková K; Krcméry V; Kubonová K
    J Chemother; 2002 Dec; 14(6):639. PubMed ID: 12583560
    [No Abstract]   [Full Text] [Related]  

  • 2. Major facilitator superfamily MfsA contributes to multidrug resistance in emerging nosocomial pathogen Stenotrophomonas maltophilia.
    Dulyayangkul P; Charoenlap N; Srijaruskul K; Mongkolsuk S; Vattanaviboon P
    J Antimicrob Chemother; 2016 Oct; 71(10):2990-1. PubMed ID: 27334664
    [No Abstract]   [Full Text] [Related]  

  • 3. The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia.
    Gröschel MI; Meehan CJ; Barilar I; Diricks M; Gonzaga A; Steglich M; Conchillo-Solé O; Scherer IC; Mamat U; Luz CF; De Bruyne K; Utpatel C; Yero D; Gibert I; Daura X; Kampmeier S; Rahman NA; Kresken M; van der Werf TS; Alio I; Streit WR; Zhou K; Schwartz T; Rossen JWA; Farhat MR; Schaible UE; Nübel U; Rupp J; Steinmann J; Niemann S; Kohl TA
    Nat Commun; 2020 Apr; 11(1):2044. PubMed ID: 32341346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial therapy for Stenotrophomonas maltophilia infections.
    Nicodemo AC; Paez JI
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):229-37. PubMed ID: 17334747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
    Nys C; Cherabuddi K; Venugopalan V; Klinker KP
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427300
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing therapy for Stenotrophomonas maltophilia.
    Muder RR
    Semin Respir Crit Care Med; 2007 Dec; 28(6):672-7. PubMed ID: 18095231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial Resistance in
    Wang Y; He T; Shen Z; Wu C
    Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29350131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.
    Senol E
    J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aph(3')-IIc, an aminoglycoside resistance determinant from Stenotrophomonas maltophilia.
    Okazaki A; Avison MB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):359-60. PubMed ID: 17088477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An update on the susceptibility of Stenotrophomonas maltophilia].
    Sevillano D; Valdezate S; Gómez-Lus ML
    Rev Esp Quimioter; 2001 Jun; 14(2):138-54. PubMed ID: 11704768
    [No Abstract]   [Full Text] [Related]  

  • 11. A meningitis case due to Stenotrophomonas maltophilia and review of the literature.
    Yemisen M; Mete B; Tunali Y; Yentur E; Ozturk R
    Int J Infect Dis; 2008 Nov; 12(6):e125-7. PubMed ID: 18579427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology and antimicrobial susceptibility of Stenotrophomonas maltophilia in a Bulgarian university hospital over a 5-year period (2007-2012).
    Bojkova M; Markovska R; Stoeva T; Strateva T; Ivanova D; Popova V; Mitov I
    Infect Dis (Lond); 2015; 47(12):932-4. PubMed ID: 26198085
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Stenotrophomonas maltophilia in hospital-acquired infection.
    Looney WJ
    Br J Biomed Sci; 2005; 62(3):145-54; quiz 1 p following 154. PubMed ID: 16196464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
    Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
    Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.
    Al-Jasser AM
    Ann Clin Microbiol Antimicrob; 2006 Sep; 5():23. PubMed ID: 16978420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stenotrophomonas maltophilia responsible for respiratory infections in neonatal intensive care unit: antibiotic susceptibility and molecular typing.
    Abbassi MS; Touati A; Achour W; Cherif A; Jabnoun S; Khrouf N; Ben Hassen A
    Pathol Biol (Paris); 2009 Jul; 57(5):363-7. PubMed ID: 18178029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-antibiotic effect (PAE) of moxifloxacin in multidrug-resistant Stenotrophomonas maltophilia.
    Korakianitis I; Mirtsou V; Gougoudi E; Raftogiannis M; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2010 Oct; 36(4):387-9. PubMed ID: 20674284
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution of integrons, and SmeABC and SmeDEF efflux pumps to multidrug resistance in clinical isolates of Stenotrophomonas maltophilia.
    Chang LL; Chen HF; Chang CY; Lee TM; Wu WJ
    J Antimicrob Chemother; 2004 Mar; 53(3):518-21. PubMed ID: 14749340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on molecular epidemiology of Stenotrophomonas maltophilia in intensive care units].
    Yue W; Huang S; Nie S
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Nov; 24(11):651-4. PubMed ID: 16136901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Septic arthritis of the knee by Stenotrophomonas maltophilia].
    Piñol I; Alier A; Hinarejos P; Sorli ML; Puig L
    Rev Esp Quimioter; 2012 Sep; 25(3):218-9. PubMed ID: 22987269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.